Brancaccio D - Search Results

1

[Assessment of geometric, biomechanical, and osteodensitometric properties of the ultradistal radius with peripheral quantitative computerized tomography in uremic patients with severe hyperparathyroidism].

Di Leo C, Tarolo GL, Bestetti A, Tagliabue L, Del Sole A, Aliberti G, Ardemagni A, Gallieni M, Brancaccio D, Froehlich W. Di Leo C, et al. Among authors: brancaccio d. Radiol Med. 1999 Apr;97(4):229-35. Radiol Med. 1999. PMID: 10414254 Italian.

2

Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach.

Brancaccio D, Cozzolino M, Gallieni M. Brancaccio D, et al. J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S21-4. doi: 10.1097/01.asn.0000093369.09194.12. J Am Soc Nephrol. 2004. PMID: 14684666 Review.

3

Vascular calcification in uremic conditions: new insights into pathogenesis.

Cozzolino M, Gallieni M, Brancaccio D. Cozzolino M, et al. Among authors: brancaccio d. Semin Nephrol. 2006 Jan;26(1):33-7. doi: 10.1016/j.semnephrol.2005.06.008. Semin Nephrol. 2006. PMID: 16412823 Review.

4

Hyperparathyroidism and anemia in renal failure.

Gallieni M, Corsi C, Brancaccio D. Gallieni M, et al. Among authors: brancaccio d. Am J Nephrol. 2000 Mar-Apr;20(2):89-96. doi: 10.1159/000013563. Am J Nephrol. 2000. PMID: 10773607 Review.

5

Cardiac and pulmonary calcification in a hemodialysis patient: partial regression 4 years after parathyroidectomy.

Di Leo C, Gallieni M, Bestetti A, Tagliabue L, Cozzolino M, Carpani P, Pozzato C, Tarolo GL, Brancaccio D. Di Leo C, et al. Among authors: brancaccio d. Clin Nephrol. 2003 Jan;59(1):59-63. doi: 10.5414/cnp59059. Clin Nephrol. 2003. PMID: 12572933

6

[Mechanism of uremic osteodystrophy and prevention of hyperparathyroidism in the uremic patient].

Brancaccio D, Cozzolino M, Galassi A, Bellasi A, Carpani P, Gallieni M. Brancaccio D, et al. G Ital Nefrol. 2003 May-Jun;20 Suppl 22:S12-6. G Ital Nefrol. 2003. PMID: 12851915 Review. Italian.

7

Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? I. Medical intervention is the primary option in the treatment of advanced hyperparathyroidism in chronic renal failure.

Gallieni M, Brancaccio D. Gallieni M, et al. Among authors: brancaccio d. Nephrol Dial Transplant. 1994;9(12):1816-9. Nephrol Dial Transplant. 1994. PMID: 7708274 No abstract available.

8

Recent advances in intravenous calcitriol treatment.

Brancaccio D, Gallieni M. Brancaccio D, et al. Curr Opin Nephrol Hypertens. 1994 Jul;3(4):411-6. doi: 10.1097/00041552-199407000-00006. Curr Opin Nephrol Hypertens. 1994. PMID: 8076144 Review.

9

Severe cortical and trabecular osteopenia in secondary hyperparathyroidism.

Brancaccio D, Di Leo C, Bestetti A, Carpani P, Tagliabue L, Cozzolino M, Galassi A, Luigi Tarolo G, Gallieni M. Brancaccio D, et al. Hemodial Int. 2003 Apr 1;7(2):122-9. doi: 10.1046/j.1492-7535.2003.00021.x. Hemodial Int. 2003. PMID: 19379351

10

Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale.

Gallieni M, Brancaccio D, Antonucci F, Bellinghieri G, Carpani P, Cozzolino M, D'Agostino F, Del Mastro G, Mallamace A, Memoli B. Gallieni M, et al. Among authors: d agostino f, brancaccio d. Clin Nephrol. 2000 Mar;53(3):188-93. Clin Nephrol. 2000. PMID: 10749297 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters